Internal Server Error

About Xcellerant Ventures

Xcellerant Ventures is a venture capital firm founded in 2020. It is primarily based out of United States. As of Mar 2026, Xcellerant Ventures is an active investor, having invested in 12 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and FinTech. Most recently it participated in the $***** Series A round of Lenoss Medical Overall, Xcellerant Ventures portfolio has seen 1 acquisition, namely TTI. A lot of funds co-invest with Xcellerant Ventures, with names like Osage Venture Partners sharing a substantial percentage of its portfolio. Xcellerant Ventures has team of 9 people including 5 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Series A & Series B
Portfolio Acquisitions
Deals in last 12 months

Xcellerant Ventures' List of Top Investments

Xcellerant Ventures has a portfolio of 12 companies. Their most notable investments are in Tesis Labs and CRISPR QC.Their portfolio spans across United States and France. They have invested in HealthTech, Enterprise Applications, FinTech and 3 other sectors, across stages such as Series A, Series B stages. Here is the list of top investments by Xcellerant Ventures:
Cloud-based patient engagement platform. The platform also allows the patient to manage medications, track pain levels, and record health metrics outside the provider visit. Using the patient’s mobile phone, this information is transferred wirelessly and paperless to the healthcare provider at check-in, eliminating the intake forms.

Key facts about Informed Mindset Medical

Key facts about Porter

Nanodropper manufactures adaptors that reduce the volume of the droplet coming from the eyedrop bottle, reducing the chances for overdosing, wastage and cost. This adaptor is a one-size-fits-most for a specific bottle type making it useful for most of the eyedrop bottles.

Key facts about Nanodropper

Key facts about Lenoss Medical

{}

Key facts about CRISPR QC

  • Founded Year: 2021
  • Location: San Diego (United States)
  • Stage: Series A
  • Total Funding till date: $12.5M
  • Employee Count: 5 as on Jul 01, 2024
  • Investors: Serra Ventures, EvoNexus and 1 Other
  • Latest Funding Round: Series A, Jan 02, 2024, $*****
  • Highlight: Editors' Pick

Xcellerant Ventures' Investments by Stage

Xcellerant Ventures has made 5 investments in Series A stage with an average round size of $4.64M and 1 investment in Series B stage with an average round size of $20M.
Here are Xcellerant Ventures' investments by stage:
Stage of entry
No. of Investments
Series A
5
Series B
1
Breakdown of Xcellerant Ventures' investments by stage of entrySeries A (5)Series B (1)
Note: We have considered here, only first round of investments

Xcellerant Ventures' Investments by Sector

Xcellerant Ventures has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, Vertical SaaS and Healthcare. Notably, it has invested in 10 Enterprise (B2B) companies, 9 Tech companies, 6 Software companies and at least 2 companies focusing on Consumer (B2C).
Here are Xcellerant Ventures' investments by sector:
Sector
No. of Investments
HealthTech
3
Enterprise Applications
2
Life Sciences
2
Vertical SaaS
2
Healthcare
1
Others
1
Breakdown of Xcellerant Ventures' investments by sectorsHealthTech (3)Enterprise Applic... (2)
Note: We have considered here, only first round of investments

Xcellerant Ventures' Investments by Geography

Xcellerant Ventures has made most investments in United States (6).

Xcellerant Ventures' recent investments

Xcellerant Ventures has made 1 investments in 2026 so far - Lenoss Medical.
Here are the most recent investments by Xcellerant Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Mar 17, 2026
United States
Series A
8684
Sep 03, 2025
United States
Series A
9665
-
Sep 18, 2024
United States
Series A
4540
Jan 02, 2024
United States
Series A
8568
-
Dec 13, 2023
United States
Series A
3690
-

Acquired companies in Xcellerant Ventures' Portfolio

1 company from Xcellerant Ventures' portfolio has been acquired. The most recent acquisition was TTI in Jun 2023 by Inframark for $*****.
Here are Xcellerant Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jun 28, 2023
-
-
8972

Team profile of Xcellerant Ventures

Xcellerant Ventures has a team of 9 members including 5 Partners and 1 Principal located in United States and Pakistan. Xcellerant Ventures' team does not sit on the board of any company as of now.
Here is a list of all team members in Xcellerant Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Los Angeles
-
Partner
Phoenix
-
Partner
Paradise Valley
-
Partner
Scottsdale
-
Partner
Phoenix
-
Principal
Lahore
-
-

Co-investors of Xcellerant Ventures

Over the past 5 years, 22 investors have co-invested in Xcellerant Ventures's portfolio companies. This includes only funds.

Recent News related to Xcellerant Ventures

View all news related to Xcellerant Ventures

FAQs about Xcellerant Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford